After randomized, controlled trials established that consumption of folic acid before pregnancy and during the early weeks of gestation reduces the risk of a neural tube defect (NTD)-affected pregnancy, the United States Public Health Service recommended in 1992 that all women capable of becoming pregnant consume 400 μg folic acid daily. In 1998, folic acid fortification of all enriched cereal grain product flour was fully implemented in the United States and Canada.
Objective
To provide guidance on national fortification of wheat and maize flours to prevent 50 to 70% of the estimated 300,000 NTD-affected pregnancies worldwide.
Methods
An expert workgroup reviewed the latest evidence of effectiveness of folic acid flour fortification and the safety of folic acid.
Results
Recent estimates show that in the United States and Canada, the additional intake of about 100 to 150 μg/day of folic acid through food fortification has been effective in reducing the prevalence of NTDs at birth and increasing blood folate concentrations in both countries. Most potential adverse effects associated with folic acid are associated with extra supplement use not mandatory fortification. Fortification of wheat flour has a proven record of prevention in other developed countries. In 2009, 51 countries had regulations written for mandatory wheat flour fortification programs that included folic acid.
Conclusions
NTDs remain an important cause of perinatal mortality and infantile paralysis worldwide. Mandatory fortification of flour with folic acid has proved to be one of the most successful public health interventions in reducing the prevalence of NTD-affected pregnancies. Most developing countries have few, if any, common sources of folic acid, unlike many developed countries, which have folic acid available from ready-to-eat cereals and supplements. Expanding the number of developed and developing countries with folic acid flour fortification has tremendous potential to safely eliminate most folic acid-preventable NTDs.
MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. Lancet1991;338:131–7.
2.
CzeizelAEDudasI. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med1992;327:1832–5.
3.
BerryRJLiZEricksonJDLiSMooreCAWangHMulinareJZhaoPWongLYGindlerJHongSXCorreaA. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med1999;341:1485–90.
4.
Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep1992;41:1–7.
5.
RayJGSinghGBurrowsRF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG2004;111:399–408.
6.
Imhoff-KunschBFloresRDaryOMartorellR. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr2007;137:1017–22.
7.
FinerLBHenshawSK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health2006;38:90–6.
8.
NevinNC. Recurrence risk of neural tube defects. Lancet1980;1:1301–2.
9.
Centers for Disease Control and Prevention. Use of dietary supplements containing folic acid among women of childbearing age—US, 2005. MMWR Morb Mortal Wkly Rep2005;54:955–8.
10.
Centers for Disease Control and Prevention. Use of supplements containing folic acid among women of childbearing age—United States, 2007. MMWR Morb Mortal Wkly Rep2008;57:5–8.
11.
BusbyAAbramskyLDolkHArmstrongB. Preventing neural tube defects in Europe: Population based study. BMJ2005;330:574–5.
12.
BlanckHMGillespieCKimmonsJESeymourJDSerdulaMK. Trends in fruit and vegetable consumption among U.S. men and women, 1994–2005. Prev Chronic Dis2008;5:A35.
13.
BusbyAAbramskyLDolkHArmstrongBAddorMCAnnerenGArmstrongNBaguetteABarisicIBergholdABiancaSBrazPCalzolariEChristiansenMCocchiGDaltveitAKDe WalleHEdwardsGGattMGenerBGillerotYGjergjaRGoujardJHaeuslerMLatos-BielenskaAMcDonnellRNevilleAOlarsBPortilloIRitvanenARobert-GnansiaERöschCScaranoGSteinbickerV. Preventing neural tube defects in Europe: A Missed opportunity. Reprod Toxicol2006;20:393–402.
14.
BottoLDLisiARobert-GnansiaEEricksonJDVollsetSEMastroiacovoPBottingBCocchiGde ViganCde WalleHFeijooMIrgensLMMcDonnellBMerlobPRitvanenAScaranoGSiffelCMetnekiJStollCSmithellsRGoujardJ. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: Are the recommendations working?BMJ2005;330:571–3.
15.
BowerC. Fortification of food with folic acid and the prevention of neural tube defects. N Z Med J2003;116:U292.
16.
Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid, Final Rule. 21 CFR Parts 136, 137, and 139. Fed Regist1996;64:8781–97.
Food Safety Authority of Ireland. Report of the National Committee on Folic Acid Food Fortification. Available at: http://www.fsai.ie/uploadedFiles/folic_acid.pdf. Accessed 8 February 2010.
20.
Scientific Advisory Committee on Nutrition. Folate and disease prevention. Norwich, UK: The Stationery Office, 2006.
21.
Health Council of The Netherlands. Towards an optimal use of folic acid. Publication no. 2008/02E. The Hague: Health Council of The Netherlands, 2008.
22.
Flour Fortification Initiative. Report of the Workshop on Wheat Flour Fortification, Cuernavaca, Mexico, 1–3 December 2004. Available at: http://www.sph.emory.edu/wheatflour/CKPAFF/index.htm. Accessed 20 November 2009.
23.
BerryRJCarterHKYangQ. Cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr2007;86:265–7; author reply 67–9.
24.
YeungLYangQBerryRJ. Contributions of total daily intake of folic acid to serum folate concentrations. JAMA2008;300:2486–7.
Food and Drug Administration. Food additives permitted for direct addition to food for human consumption; folic acid (folacin), Final Rule. Fed Regist1996;64: 8797–807.
27.
Institute of Medicine. Folate. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academies Press; 1998:196–305.
28.
SelhubJJacquesPFDallalGChoumenkovitchSRogersG. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull2008;29:S67–73.
29.
DalyLEKirkePNMolloyAWeirDGScottJM. Folate levels and neural tube defects. Implications for prevention. JAMA1995;274:1698–702.
30.
CuskellyGJMcNultyHScottJM. Effect of increasing dietary folate on red-cell folate: Implications for prevention of neural tube defects. Lancet1996;347:657–9.
31.
McLeanEde BenoistBAllenLH. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr Bull2008;29:S38–51.
32.
ChristiansonAModellBHowsonC. March of Dimes global report on birth defects: the hidden toll of dying and disabled children. White Plains, NY, USA: March of Dimes Foundation, 2006.
33.
BellKNOakleyGPJr. Tracking the prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol2006;76:654–7.
MurphyMKeatingMBoylePWeirDGScottJM. The elucidation of the mechanism of folate catabolism in the rat. Biochem Biophys Res Commun1976;71:1017–24.
36.
EitenmillerRLinYLandenWO. Folate and folic acid. In: Vitamin analysis for the health and food sciences, 2nd ed. Boca Raton, Fla, USA: CRC Press, 2007:453–465.
37.
O'BroinJDTemperleyIJBrownJPScottJM. Nutritional stability of various naturally occurring monoglutamate derivatives of folic acid. Am J Clin Nutr1975;28:438–44.
38.
TempleCMontgomeryJA. Chemical and physical properties of folic acid and reduced derivatives. New York: John Wiley, 1984.
39.
AndersonRMaxwellDLMulleyAEFritschCW. Effects of processing and storage on micronutrients in breakfast cereals. Food Technol1976;30:110–4.
40.
CortWBorensteinBHarleyJHOsadcaMScheimerJ. Nutrient stability of fortified cereal products. Food Technol1976;30:52–62.
41.
ColmanNGreenRMetzJ. Prevention of folate deficiency by food fortification. II. Absorption of folic acid from fortified staple foods. Am J Clin Nutr1975;28:459–64.
42.
KeagyPStokstadELRFellerDA. Folacin stability during bread processing and family flour storage. Cereal Chem1975;52:348–56.
43.
RubinSEmodiAScialpiL. Micronutrient additions to cereal grain products. Cereal Chem1977;54:895–904.
44.
PfeifferCFaziliZZhangM. Folate analytical methodology. In: BaileyLB, ed. Folate in health and disease, 2nd ed. Boca Raton, Fla, USA: CRC Press, 2009:517–574.
45.
TamuraT. Determination of food folate. J Nutr Biochem1998;9:285–93.
46.
DeVriesJWRaderJIKeagyPMHudsonCAAngyalGArcotJCastelliMDoreanuNHudsonCLawrencePMartinJPeaceRRosnerLStrandlerHSSzpylkaJvan den BergHWoCWurzC. Microbiological assay-trienzyme procedure for total folates in cereals and cereal foods: Collaborative study. J AOAC Int2005;88:5–15.
47.
PfeifferCRogersLMGregoryJF. Determination of folate in cereal-grain food products using tri-enzyme extraction and combined affinity and reverse-phase liquid chromatography. J Agric Food Chem1997;45:407–13.
48.
GregoryJF3rd. Chemical and nutritional aspects of folate research: Analytical procedures, methods of folate synthesis, stability, and bioavailability of dietary folates. Adv Food Nutr Res1989;33:1–101.
49.
WinkelsRMBrouwerIASiebelinkEKatanMBVerhoefP. Bioavailability of food folates is 80% of that of folic acid. Am J Clin Nutr2007;85:465–73.
50.
KoningsEJRoomansHHDorantEGoldbohmRASarisWHvan den BrandtPA. Folate intake of the Dutch population according to newly established liquid chromatography data for foods. Am J Clin Nutr2001;73:765–76.
51.
ArcotJShresthaA. Folate: Methods of analysis. Trends Food Sci Technol2005;16:253–66.
52.
PfeifferCMRogersLMBaileyLBGregoryJF3rd. Absorption of folate from fortified cereal-grain products and of supplemental folate consumed with or without food determined by using a dual-label stable-isotope protocol. Am J Clin Nutr1997;66:1388–97.
53.
KoontzJLPhillipsKMWunderlichKMExlerJHoldenJMGebhardtSEHaytowitzDB. Comparison of total folate concentrations in foods determined by microbiological assay at several experienced U.S. commercial laboratories. J AOAC Int2005;88:805–13.
54.
PuwastienPPinprapaiaNJudprasongaKTamuraT. International inter-laboratory analyses of food folate. J Food Comp Anal2005;18:387–97.
55.
American Association of Analytical Chemists. Total folate in cereals and cereal foods: microbiological assay-trienzyme procedure, 17th ed. Gaithersburg, Md, USA: AOAC International, 2005.
56.
FaziliZPfeifferCMZhangM. Comparison of serum folate species analyzed by LC-MS/MS with total folate measured by microbiologic assay and Bio-Rad radioassay. Clin Chem2007;53:781–4.
57.
O'BroinSKelleherB. Microbiological assay on microtitre plates of folate in serum and red cells. J Clin Pathol1992;45:344–7.
58.
MolloyAMScottJM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol1997;281:43–53.
59.
PfeifferCMFaziliZMcCoyLZhangMGunterEW. Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin Chem2004;50:423–32.
60.
FaziliZPfeifferCM. Measurement of folates in serum and conventionally prepared whole blood lysates: Application of an automated 96-well plate isotope-dilution tandem mass spectrometry method. Clin Chem2004;50:2378–81.
61.
RaitenDJFisherKD. Assessment of folate methodology used in the Third National Health and Nutrition Examination Survey (NHANES III, 1988–1994). J Nutr1995;125:1371S–98S.
62.
SatterfieldMBSniegoskiLTSharplessKEWelchMJHornikovaAZhangNFPfeifferCMFaziliZZhangMNelsonBC. Development of a new standard reference material: SRM 1955 (homocysteine and folate in human serum). Anal Bioanal Chem2006;385:612–22.
63.
McNultyHPentievaK. Folate bioavailability. In: BaileyLB, ed. Folate in health and disease, 2nd ed. Boca Raton, Fla, USA: CRC Press, 2009:25–47.
64.
SauberlichHEKretschMJSkalaJHJohnsonHLTaylorPC. Folate requirement and metabolism in non-pregnant women. Am J Clin Nutr1987;46:1016–28.
65.
BrouwerIAvan DusseldorpMWestCEMeyboomSThomasCMDuranMvan het HofKHEskesTKHautvastJGSteegers-TheunissenRP. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr1999;129:1135–9.
66.
Hannon-FletcherMPArmstrongNCScottJMPentievaKBradburyIWardMStrainJJDunnAAMolloyAMKerrMAMcNultyH. Determining bioavailability of food folates in a controlled intervention study. Am J Clin Nutr2004;80:911–8.
67.
YangTLHungJCaudillMAUrrutiaTFAlamillaAPerryCALiRHataHCoggerEA. A long-term controlled folate feeding study in young women supports the validity of the 1.7 multiplier in the dietary folate equivalency equation. J Nutr2005;135:1139–45.
68.
KellyPMcPartlinJGogginsMWeirDGScottJM. Unmetabolized folic acid in serum: Acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr1997;65:1790–5.
69.
SweeneyMRMcPartlinJScottJ. Folic acid fortification and public health: Report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health2007;7:41.
70.
SweeneyMRMcPartlinJWeirDGDalyLScottJM. Postprandial serum folic acid response to multiple doses of folic acid in fortified bread. Br J Nutr2006;95:145–51.
71.
RockCL. Multivitamin-multimineral supplements: Who uses them?Am J Clin Nutr2007;85:277S–9S.
72.
KalmbachRDChoumenkovitchSFTroenAMD'AgostinoRJacquesPFSelhubJ. Circulating folic acid in plasma: Relation to folic acid fortification. Am J Clin Nutr2008;88:763–8.
73.
ChenLTRiveraMA. The Costa Rican experience: Reduction of neural tube defects following food fortification programs. Nutr Rev2004;62:S40–3.
74.
HertrampfECortesFEricksonJDCayazzoMFreireWBaileyLBHowsonCKauwellGPPfeifferC. Consumption of folic acid-fortified bread improves folate status in women of reproductive age in Chile. J Nutr2003;133:3166–9.
75.
Centers for Disease Control and Prevention. Folate status in women of childbearing age, by race/ethnicity—United States, 1999–2000. MMWR Morb Mortal Wkly Rep2002;51:808–10.
76.
RayJGVermeulenMJBossSCColeDE. Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology2002;13:238–40.
77.
De WalsPTairouFVan AllenMIUhSHLowryRBSibbaldBEvansJAVan den HofMCZimmerPCrowleyMFernandezBLeeNSNiyonsengaT. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med2007;357:135–42.
78.
WilliamsLJRasmussenSAFloresAKirbyRSEdmondsLD. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics2005;116:580–6.
79.
SayedARBourneDPattinsonRNixonJHendersonB. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res A Clin Mol Teratol2008;82:211–6.
80.
PfeifferCMJohnsonCLJainRBYetleyEAPiccianoMFRaderJIFisherKDMulinareJOsterlohJD. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988–2004. Am J Clin Nutr2007;86:718–27.
81.
LiuSWestRRandellELongerichLO'ConnorKSScottHCrowleyMLamAPrabhakaranVMcCourtC. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth2004;4:20. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524178. Accessed 23 December 2009.
82.
HunterRBarnesJOakeleyHFMatthewsDM. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet1970;1:61–3.
83.
GibberdFBNichollsADunneJFChaput de SaintongeDM. Toxicity of folic acid. Lancet1970;1:360–1.
84.
HellstromL. Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet1971;1:59–61.
85.
RichensA. Toxicity of folic acid. Lancet1971;1:912.
86.
SheehyTW. Folic acid: Lack of toxicity. Lancet1973;1:37.
87.
SpiesTDSuarezRMSuarezRMJrHernandez-MoralesF. The therapeutic effect of folic acid in tropical sprue. Science1946;104:75–76.
88.
UlrichCM. Folate and cancer prevention: A Closer look at a complex picture. Am J Clin Nutr2007;86:271–3.
89.
UlrichCMPotterJD. Folate and cancer—timing is everything. JAMA2007;297:2408–9.
90.
KimYI. Folic acid fortification and supplementation—good for some but not so good for others. Nutr Rev2007;65:504–11.
91.
BaystonRRussellAWaldNJHoffbrandAV. Folic acid fortification and cancer risk. Lancet2008;371:1335–6.
92.
KimYI. Folic acid supplementation and cancer risk: Point. Cancer Epidemiol Biomarkers Prev2008;17:2220–5.
93.
UlrichCM. Folate and cancer prevention—where to next? Counterpoint. Cancer Epidemiol Biomarkers Prev2008;17:2226–30.
94.
JohnstonRB. Will increasing folic acid in fortified grain products further reduce neural tube defects without causing harm?: Consideration of the evidence. Pediatr Res2008;63:2–8.
95.
SmithADKimYIRefsumH. Is folic acid good for everyone?Am J Clin Nutr2008;87:517–33.
96.
MasonJB. Folate, cancer risk, and the Greek god, Proteus: A Tale of two chameleons. Nutr Rev2009;67:206–12.
97.
MillsJLVon KohornIConleyMRZellerJACoxCWilliamsonREDufourDR. Low vitamin B-12 concentrations in patients without anemia: The effect of folic acid fortification of grain. Am J Clin Nutr2003;77:1474–7.
98.
MetzJMcNeilARLevinM. The relationship between serum cobalamin concentration and mean red cell volume at varying concentrations of serum folate. Clin Lab Haematol2004;26:323–5.
99.
WyckoffKFGanjiV. Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period. Am J Clin Nutr2007;86:1187–92.
100.
YajnikCSDeshpandeSSJacksonAARefsumHRaoSFisherDJBhatDSNaikSSCoyajiKJJoglekarCVJoshiNLubreeHGDeshpandeVURegeSSFallCH. Vitamin B(12) and folate concentrations during pregnancy and insulin resistance in the offspring: The Pune Maternal Nutrition Study. Diabetologia2008;51:29–38.
101.
StewartCPChristianPSchulzeKJLeclerqSCWestKPJrKhatrySK. Antenatal micronutrient supplementation reduces metabolic syndrome in 6- to 8-year-old children in rural Nepal. J Nutr2009;139:1575–81.
102.
MasonJBDicksteinAJacquesPFHaggartyPSelhubJDallalGRosenbergIH. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: A Hypothesis. Cancer Epidemiol Biomarkers Prev2007;16:1325–9.
LawrenceJMPetittiDBWatkinsMUmekuboMA. Trends in serum folate after food fortification. Lancet1999;354:915–6.
105.
HirschSSanchezHAlbalaCde la MazaMPBarreraGLeivaLBunoutD. Colon cancer in Chile before and after the start of the flour fortification program with folic acid. Eur J Gastroenterol Hepatol2009;21:436–9.
106.
DonosoAVillarroelLPinedoG. [Increase in colon cancer mortality rates in Chile, during the period 1990–2003]. Rev Med Chil2006;134:152–8.
107.
ColeBFBaronJASandlerRSHaileRWAhnenDJBresalierRSMcKeown-EyssenGSummersRWRothsteinRIBurkeCASnoverDCChurchTRAllenJIRobertsonDJBeckGJBondJHByersTMandelJSMottLAPearsonLHBarryELReesJRMarconNSaibilFUelandPMGreenbergER. Folic acid for the prevention of colorectal adenomas: A Randomized clinical trial. JAMA2007;297:2351–9.
108.
LoganRFGraingeMJShepherdVCArmitageNCMuirKR. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology2008;134:29–38.
109.
JaszewskiRMisraSTobiMUllahNNaumoffJAKucukOLeviEAxelrodBNPatelBBMajumdarAP. Folic acid supplementation inhibits recurrence of colorectal adenomas: A Randomized chemoprevention trial. World J Gastroenterol2008;14:4492–8.
110.
MorrisMCEvansDABieniasJLTangneyCCHebertLEScherrPASchneiderJA. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol2005;62:641–5.
111.
MorrisMSJacquesPFRosenbergIHSelhubJ. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr2007;85:193–200.
112.
DurgaJvan BoxtelMPSchoutenEGKokFJJollesJKatanMBVerhoefP. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: A Randomised, double blind, controlled trial. Lancet2007;369:208–16.
113.
McMahonJAGreenTJSkeaffCMKnightRGMannJIWilliamsSM. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med2006;354:2764–72.
114.
CzeizelAEMetnekiJDudasI. Higher rate of multiple births after periconceptional vitamin supplementation. N Engl J Med1994;330:1687–8.
115.
EricsonAKallenBAbergA. Use of multivitamins and folic acid in early pregnancy and multiple births in Sweden. Twin Res2001;4:63–6.
116.
KallenB. Use of folic acid supplementation and risk for dizygotic twinning. Early Hum Dev2004;80:143–51.
117.
CzeizelAEVarghaP. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol2004;191:790–4.
118.
VollsetSEGjessingHKTandbergARonningTIrgensLMBasteVNilsenRMDaltveitAK. Folate supplementation and twin pregnancies. Epidemiology2005;16:201–5.
119.
BerryRJKihlbergRDevineO. Impact of mis classification of in vitro fertilisation in studies of folic acid and twinning: Modelling using population based Swedish vital records. BMJ2005;330:815–8.
120.
LiZGindlerJWangHBerryRJLiSCorreaAZhengJCEricksonJDWangY. Folic acid supplements during early pregnancy and likelihood of multiple births: A Population-based cohort study. Lancet2003;361:380–4.
121.
KucikJCorreaA. Trends in twinning rates in metropolitan Atlanta before and after folic acid fortification. J Reprod Med2004;49:707–12.
122.
LawrenceJMWatkinsMLChiuVEricksonJDPetittiDB. Food fortification with folic acid and rate of multiple births, 1994–2000. Birth Defects Res A Clin Mol Teratol2004;70:948–52.
123.
ShawGMCarmichaelSLNelsonVSelvinSSchafferDM. Food fortification with folic acid and twinning among California infants. Am J Med Genet A2003;119A:137–40.
124.
SignoreCMillsJLCoxCTrumbleAC. Effects of folic acid fortification on twin gestation rates. Obstet Gynecol2005;105:757–62.
125.
WallerDKTitaATAnnegersJF. Rates of twinning before and after fortification of foods in the US with folic acid, Texas, 1996 to 1998. Paediatr Perinat Epidemiol2003;17:378–83.
126.
HaggartyPMcCallumHMcBainHAndrewsKDuthieSMcNeillGTempletonAHaitesNCampbellDBhattacharyaS. Effect of B vitamins and genetics on success of in-vitro fertilisation: Prospective cohort study. Lancet2006;367:1513–9.
127.
HookEBCzeizelAE. Can terathanasia explain the protective effect of folic-acid supplementation on birth defects?Lancet1997;350:513–5.
128.
GindlerJLiZBerryRJZhengJCorreaASunXWongLChengLEricksonJDWangYTongQ. Folic acid supplements during pregnancy and risk of miscarriage. Lancet2001;358:796–800.
129.
GeorgeLMillsJLJohanssonALNordmarkAOlanderBGranathFCnattingiusS. Plasma folate levels and risk of spontaneous abortion. JAMA2002;288:1867–73.
130.
HasanROlshanAFHerringAHSavitzDASiega-RizAMHartmannKE. Self-reported vitamin supplementation in early pregnancy and risk of miscarriage. Am J Epidemiol2009;169:1312–8.
131.
NelenWLBlomHJSteegersEAden HeijerMThomasCMEskesTK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol2000;95:519–24.
132.
RayJGLaskinCA. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A Systematic review. Placenta1999;20:519–29.
133.
TroenAMMitchellBSorensenBWenerMHJohnstonAWoodBSelhubJMcTiernanAYasuiYOralEPotterJDUlrichCM. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr2006;136:189–94.
134.
KimYIHayekMMasonJBMeydaniSN. Severe folate deficiency impairs natural killer cell-mediated cytotoxicity in rats. J Nutr2002;132:1361–7.
135.
EricksonKLMedinaEAHubbardNE. Micronutrients and innate immunity. J Infect Dis2000;182(suppl 1):S5–10.
136.
DaryO. Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12. Food Nutr Bull2008;29:S214–24.
137.
ShibuyaKMurrayCJL. Congenital anomalies. In: MurrayCJLLopezAD, eds. Health dimensions of sex and reproduction. Boston, Mass, USA: Harvard School of Public Health/Harvard University Press, 1998:455–512.
138.
International Centre for Birth Defects. World atlas of birth defects, 2nd ed. Geneva: World Health Organization, 1993.
